| CAT # |
Product Name |
Description |
| CPD101316 |
(S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethanamin... |
|
| CPD102238 |
ML 265；CID44246499；NCGC 00186528；TEPP46 |
TEPP-46 (ML-265) is an effective and selective activator of pyruvate kinase M2 (PKM2). |
| CPDD0995 |
Bardoxolone methyl;RTA 402;NSC 713200;TP155;CDDOMe |
The synthetic oleanane triterpenoid CDDO (Item No. 81035) is a Nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells. |
| CPD0854 |
Sotagliflozin;LX-4211 |
Sotagliflozin (LX-4211) is an SGLT1/2 inhibitor and an anti diabetes agent. |
| CPDM400236 |
methyl 2-chloro-4-methoxy-5-(4,4,5,5-tetramethy... |
|
| CPDP802017 |
CB-Cyclam(M-200) |
CB Cyclam is a bifunctional chelating agent (BFC), which is a derivative of the macrocyclic ligand tetradecane main chain Cyclen. |
| CPD1111 |
MAK683; EED inhibitor 1 |
MAK683 is an inhibitor of embryonic ectoderm development (EED) |
| CPDP801902 |
(2S,4R)-1-((S)-17-amino-2-(tert-butyl)-4-oxo-6,... |
|
| CPDM400221 |
tert-Butyl 3-methyl-4-oxo-3-(trifluoromethyl)py... |
|
| CPDM400228 |
8-bromo-5-chloro-[1,2,4]triazolo[4,3-c]pyrimidine |
|
| CPD107768 |
Icotinib HCl；BPI2009 |
Icotinib Hydrochloride (BPI-2009) is an effective and selective EGFR inhibitor |
| CPD113409 |
SGR 1505 |
SGR-1505 is an orally active MALT1 allosteric inhibitor. |
| CPD111306 |
7-bromo-2,4,6-trichloro-8-fluoroquinazoline |
|
| CPD113109 |
ARS-1323-Alkyne |
ARS-1323-alkyne, a switch-II pocket (S-IIP) inhibitor |
| CPDP801183 |
VVD-214;RO7589831;VVD-133214 |
VVD-214 is a synthetic WRN helicase lethal allosteric inhibitor. |
| CPDP801366 |
Inlexisertib;DCC-3116 |
DCC-3116 is an orally active ULK1/2 inhibitor. |
| CPDA601378 |
Nonylacridine Orange |
|
| CPD112537 |
4H-1,3-Dioxolo[4,5-c]pyrrole-4-carboxylic acid,... |
|
| CPDP801763 |
MC3138 |
MC3138 is a selective SIRT5 activator. |
| CPDP801758 |
Chk1-IN-6 |
Chk1-IN-6 is a potent, selective, and orally bioavailable CHK1 candidate inhibitor. |
| CPD113410 |
NDI-101150 |
NDI-101150 is a potent and selective inhibitor of HPK1 (hematopoietic progenitor cell kinase 1). |
| CPDA601453 |
BMS-986408 |
BMS-986408 is an orally effective dual DGK α/Zeta inhibitor. |
| CPDA601445 |
AZD0780;EX-A6975;laroprovstatum; laroprovstat |
PCSK9-IN-12 is a heteroaromatic compound. PCSK9-IN-12 has binding affinity for PCSK9 with a Kd value<200 nM. PCSK9-IN-12 can be used for the study of cholesterol metabolism. |
| CPDA601447 |
PF07328948 |
PF-07328948 is an orally effective BDK (branched chain ketone dehydrogenase kinase) inhibitor. |
| CPD112881 |
(1S)-2,2,2-trifluoro-1-methylethyl]hydrazine hy... |
|
| CPD108261 |
LOXO-305;LY 3527727;Pirtobrutinib |
Pirtobrutinib (LOXO-305) is a highly selective and non covalent next-generation BTK inhibitor that can inhibit various BTK C481 substitution mutations. |
| CPD115335 |
Luxdegalutamide; ARV-766 |
Luxdegalutamide (ARV-766) is an orally effective protein hydrolysis targeted chimeric (PROTAC) targeting androgen receptor (AR), which can degrade AR resistance related mutants. |
| CPDA601356 |
iHSP110-33 |
|
| CPDP800487 |
TNG462 |
TNG-462 is an orally effective selective PRMT5 inhibitor. |
| CPDP801649 |
1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5... |
EED ligand 1 is a diverse and effective inhibitor that targets the EED subunit of methyltransferase PRC2. |
| CPDM400208 |
6,7-Difluoro-4(3H)-quinazolinone |
|
| CPDP801752 |
N-(4-quinolinylcarbonyl)Glycine |
|
| CPDM400190 |
Methyl 5-bromo-2-methyl-3-(trifluoromethyl)benz... |
|
| CPDP800126 |
IDE397 (GSK-4362676) |
|
| CPDP801185 |
NST-628 |
NST-628 is a MAPK pathway molecular gel with blood-brain barrier permeability, which can inhibit RAF phosphorylation and MEK activation. |
| CPD115153 |
NX-2127 |
NX-2127 is an orally effective BTK inhibitor. |
| CPDP801764 |
VU0448088 (ML253) |
VU0448088 (ML253) is an effective positive allosteric modulator of tricyclic muscarinic acetylcholine receptor subtype 4 (M4) that can cross the blood-brain barrier. |
| CPDM400183 |
(4′S,5′R)-6”-chloro-4′-... |
|
| CPDM400180 |
benzyl (2-oxocyclobutyl)carbamate |
|
| CPDP801753 |
ethyl 2-((3bS,4aR)-5,5-difluoro-3-(trifluoromet... |
|
| CPDP801669 |
BN104 |
BN-104 (BNM-1192) can inhibit the Menin MLL interaction and can be used in cancer research, such as acute myeloid leukemia. |
| CPDM400179 |
Cyclopenta[c]pyrrole-1,2(1H)-dicarboxylic acid,... |
|
| CPDM400178 |
Cyclopenta[c]pyrrole-1,2(1H)-dicarboxylic acid,... |
|
| CPD101241 |
BAY-2416964；ilantimodum；ilantimod |
BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 192. |
| CPDP801685 |
2-[(2-fluorobenzoyl)amino]-N-[2-(4-morpholinyl)... |
|
| CPDP801684 |
7-methyl-2-((4-methyl-6-(1-methyl-1H-pyrazol-4-... |
DNA-PK-IN-12 (compound 31t) is an orally active DNA-PK inhibitor. |
| CPDM400166 |
3-chloro-2-(10-fluoro-8-(prop-1-yn-1-yl)-1,2,3,... |
|
| CPD111670 |
GDC6036；GDC6036 atropisomers |
The GDC6036 anti rotation isomer contains two types of GDC6036 anti rotation isomers. GDC-6036， Also known as RG6330, it is an orally bioavailable, highly efficient, and selective KRAS G12C inhibitor. |
| CPDM400167 |
7-methyl-2-(methylsulfonyl)-9-(tetrahydro-2H-py... |
|
| CPDM400131 |
2-((6-amino-5-ethylpyridin-3-yl)amino)-2-oxoace... |
|
